Direct Answer: Switch Unit-for-Unit
When switching from Humulin 30/70 to Novolin 30/70, use the same total daily dose (unit-for-unit conversion) as these are bioequivalent formulations containing identical insulin compositions (70% NPH/30% regular human insulin). Both products are 100 units/mL (U-100) concentration and have equivalent pharmacokinetic and pharmacodynamic profiles 1.
Rationale for Unit-for-Unit Conversion
The evidence strongly supports a straightforward 1:1 dose conversion:
Bioequivalence: Both Humulin 70/30 and Novolin 70/30 contain the same ratio of 70% insulin isophane (NPH) and 30% regular human insulin at identical concentrations 1
Clinical validation: Research demonstrates that unit-for-unit switching between premixed human insulin 30/70 formulations is the most effective approach, resulting in the highest proportion of patients reaching HbA1c targets with minimal need for dose titration 2
Proven safety: Studies show patients can be safely transferred on a dose-for-dose basis between different brands of 70/30 premixed insulin without increased hypoglycemia risk 3
Practical Implementation
Initial conversion approach:
- Transfer the exact same total daily dose currently used with Humulin 70/30
- Maintain the same injection schedule (typically twice daily: before breakfast and before dinner)
- The standard distribution is 2/3 of total daily dose before breakfast and 1/3 before dinner 4
Monitoring requirements:
- Check fasting and pre-dinner blood glucose for the first 3-7 days post-switch
- Assess for hypoglycemia, particularly if baseline HbA1c <8% 4
- If hypoglycemia occurs without clear cause, reduce dose by 10-20% 4
Important Caveats
Watch for these situations requiring dose adjustment:
Better glycemic control at baseline: If HbA1c <8% at time of switch, consider reducing the initial dose by 4 units per day or 10% to prevent hypoglycemia 4
Storage differences: Novolin 70/30 has different storage requirements than Humulin 70/30 once opened (check specific product labeling), which could affect insulin stability if not followed
Mixing technique: Both products require proper resuspension (roll 10 times, invert 10 times) before each use to ensure accurate dosing 1
Do not reduce the dose prophylactically unless the patient has HbA1c <8% or frequent hypoglycemia. The unit-for-unit approach minimizes the risk of hyperglycemia during transition while maintaining safety 2.
Follow-up Titration
If glycemic control is inadequate after the switch:
- Titrate by increasing 2 units every 3 days to reach fasting plasma glucose goal 4
- Reassess at 3-6 months and adjust based on HbA1c and glucose patterns 4
The key principle: simplicity equals effectiveness. Unit-for-unit switching requires the least clinical intervention and achieves optimal outcomes compared to asymmetric dose adjustments 2.